NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
6.34
+0.62 (10.84%)
At close: Oct 28, 2026, 4:00 PM EDT
6.37
+0.03 (0.47%)
After-hours: Oct 28, 2026, 7:26 PM EDT
NextCure Market Cap
NextCure has a market cap or net worth of $29.02 million as of October 28, 2026. It is the 34,133rd most valuable company in the world and the 4,983rd biggest in the United States. Its market cap has increased by 16.98% in one year.
Market Cap
29.02M
Enterprise Value
13.60M
1-Year Change
16.98%
Global Rank
Country Rank
#4,983 United States
Category
ChartMarket Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $29.02M, a decrease of -93.35%. That is a compound annual growth rate of -30.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 29.11M | -41.48% |
| Dec 31, 2025 | 49.74M | 130.37% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABVC BioPharma | 27.00M |
| Atossa Therapeutics | 25.95M |
| IGC Pharma | 25.43M |
| Immutep | 23.84M |
| Context Therapeutics | 21.99M |
| Polyrizon | 21.19M |
| Seres Therapeutics | 20.99M |
| Quoin Pharmaceuticals | 19.31M |